BioCentury
ARTICLE | Company News

Helmedix autoimmune news

February 18, 2013 8:00 AM UTC

Helmedix debuted with A$1.3 million ($1.3 million) in seed funding from Australia's Medical Research Commercialization Fund (MRCF) to develop peptides to prevent and treat autoimmune diseases. The new...